DISCO Pharmaceuticals is a startup based in Germany, most recent round Seed.
DISCO Pharmaceuticals is a startup based in Germany. Its most recent tracked round is Seed.
DISCO Pharmaceuticals develops a surfaceome mapping platform to identify cell-surface protein targets for targeted cancer therapies. Its initial discovery pipeline focuses on small cell lung cancer and microsatellite-stable colorectal cancer to enable novel therapeutic development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.